Literature DB >> 12059073

Salivary electrolyte concentrations are associated with cystic fibrosis transmembrane regulator genotypes.

Johan K M Aps1, Joris Delanghe, Luc C Martens.   

Abstract

It is estimated that about one in 24 Belgian Caucasians is a cystic fibrosis (CF) heterozygote. Until now, CF heterozygotes can only be identified by genetic decoding (e.g. Inno-Lipa CF2 test), as they cannot be phenotypically distinguished from the general population. The aim of this study was to evaluate differences in salivary electrolyte concentrations (calcium, bicarbonate, chloride, potassium, sodium and phosphate) and salivary osmolarity between CF homozygotes (n=41), CF heterozygotes (n=56) and healthy controls (n=65). Differences between the three groups were investigated by means of non-parametric tests. Several significant differences between the three study groups and among, as well as between, the different cystic fibrosis transmembrane regulator (CFTR) genotypes were observed. Significant differences in salivary electrolyte concentrations between individuals with delta F508 mutation and those without, and between CF homozygotes and heterozygotes were observed. The concentrations of several salivary electrolytes, and salivary osmolarity were significantly higher in CFTR genotype individuals. Differences in salivary electrolyte concentrations may partly explain differences in caries between the three study groups.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12059073     DOI: 10.1515/CCLM.2002.055

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  9 in total

1.  Related factors of dental caries and molar incisor hypomineralisation in a group of children with cystic fibrosis.

Authors:  S Peker; S Mete; Y Gokdemir; B Karadag; B Kargul
Journal:  Eur Arch Paediatr Dent       Date:  2014-02-26

2.  Unstimulated Saliva-Related Caries Risk Factors in Individuals with Cystic Fibrosis: A Cross-Sectional Analysis of Unstimulated Salivary Flow, pH, and Buffering Capacity.

Authors:  Alaa A Alkhateeb; Lloyd A Mancl; Richard B Presland; Marilynn L Rothen; Donald L Chi
Journal:  Caries Res       Date:  2016-11-16       Impact factor: 4.056

3.  Children with cystic fibrosis have prolonged chemical clearance of acid reflux compared to symptomatic children without cystic fibrosis.

Authors:  Frederick W Woodley; Rodrigo S Machado; Don Hayes; Carlo Di Lorenzo; Ajay Kaul; Beth Skaggs; Karen McCoy; Alpa Patel; Hayat Mousa
Journal:  Dig Dis Sci       Date:  2013-11-28       Impact factor: 3.199

4.  Elevated incidence of dental caries in a mouse model of cystic fibrosis.

Authors:  Marcelo A Catalán; Kathleen Scott-Anne; Marlise I Klein; Hyun Koo; William H Bowen; James E Melvin
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

5.  Optical coherence tomography identifies lower labial salivary gland surface density in cystic fibrosis.

Authors:  Jan K Nowak; Ireneusz Grulkowski; Karol Karnowski; Maciej Wojtkowski; Jaroslaw Walkowiak
Journal:  PLoS One       Date:  2015-01-26       Impact factor: 3.240

6.  Salivary Cytokines and Airways Disease Severity in Patients with Cystic Fibrosis.

Authors:  Alice Castaldo; Paola Iacotucci; Vincenzo Carnovale; Roberta Cimino; Renato Liguori; Marika Comegna; Valeria Raia; Gaetano Corso; Giuseppe Castaldo; Monica Gelzo
Journal:  Diagnostics (Basel)       Date:  2020-04-15

7.  Salivary Biomarkers and Oral Microbial Load in Relation to the Dental Status of Adults with Cystic Fibrosis.

Authors:  Tamara Pawlaczyk-Kamieńska; Maria Borysewicz-Lewicka; Halina Batura-Gabryel
Journal:  Microorganisms       Date:  2019-12-13

Review 8.  Role of Salivary Biomarkers in Cystic Fibrosis: A Systematic Review.

Authors:  Asma Almeslet; Sarah Alnamlah; Latifa Alanzan; Rawan Aldriwesh; Sha'eah AlWehaiby
Journal:  Biomed Res Int       Date:  2022-01-19       Impact factor: 3.411

9.  Correlations of salivary biomarkers with clinical assessments in patients with cystic fibrosis.

Authors:  Shuai Nie; Huaibin Zhang; Kathryn M Mayer; Frank G Oppenheim; Frédéric F Little; Jonathan Greenberg; Ahmet Z Uluer; David R Walt
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.